# To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers

> **NCT02017730** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (actual)

## Conditions studied

- Immunology

## Interventions

- **DRUG:** BMS-986020
- **DRUG:** [11C]BMT-136088

## Key facts

- **NCT ID:** NCT02017730
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017730, "To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02017730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*